Eiger BioPharmaceuticals (EIGR) Insider Trading & Ownership → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free EIGR Stock Alerts Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Eiger BioPharmaceuticals (NASDAQ:EIGR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.22%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$44,170.20Number OfInsiders Selling(Last 12 Months)0 Get EIGR Insider Trade Alerts Want to know when executives and insiders are buying or selling Eiger BioPharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EIGR Insider Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Eiger BioPharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/2/2023Richard A KayneMajor ShareholderBuy779$9.00$7,011.00 10/31/2023Richard A KayneMajor ShareholderBuy5,161$7.20$37,159.20 (Data available from 1/1/2013 forward) EIGR Insider Trading Activity - Frequently Asked Questions Who is on Eiger BioPharmaceuticals's Insider Roster? The list of insiders at Eiger BioPharmaceuticals includes David Apelian, Eldon C Mayer III, Richard A Kayne, Sriram Ryali, and Thomas John Dietz. Learn more on insiders at EIGR. What percentage of Eiger BioPharmaceuticals stock is owned by insiders? 4.22% of Eiger BioPharmaceuticals stock is owned by insiders. Learn more on EIGR's insider holdings. Which Eiger BioPharmaceuticals insiders have been buying company stock? The following insiders have purchased EIGR shares in the last 24 months: Richard A Kayne ($44,170.20), and Thomas John Dietz ($71,471.40). How much insider buying is happening at Eiger BioPharmaceuticals? Insiders have purchased a total of 7,606 EIGR shares in the last 24 months for a total of $115,641.60 bought. Which Eiger BioPharmaceuticals insiders have been selling company stock? The following insiders have sold EIGR shares in the last 24 months: David Apelian ($48,853.80), Eldon C Mayer III ($4,686.60), and Thomas John Dietz ($26,325.00). How much insider selling is happening at Eiger BioPharmaceuticals? Insiders have sold a total of 1,062 Eiger BioPharmaceuticals shares in the last 24 months for a total of $79,865.40 sold. More Insider Trading Tools from MarketBeat Related Companies: REVB Insider Ownership NMTR Insider Ownership SQL Insider Ownership NH Insider Ownership NOVN Insider Ownership AGRX Insider Ownership CWBR Insider Ownership GMDA Insider Ownership NUWE Insider Ownership CNSP Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:EIGR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eiger BioPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
